What's New

(16 June 2022, Hong Kong) A clinical study by HKSH Medical Group (HKSH) found that the combination of stereotactic body radiotherapy (SBRT) and magnetic resonance-guided radiation therapy (MRgRT) offers the potential for achieving better treatment outcome for prostate cancer patients. The research was published as Asia’s first MR Linac clinical study for localised prostate...